Generic medicines contracts

• The five suppliers that won the most generic medicines contracts took 43% of them (29 of 67).
• The median contract, £439k, is 4.2 times the median across healthcare contracts (£106k).
• Northern Ireland had the most contracts: 36, or 54% of the total.

1. 1Belfast Health and Social Care Trust22 contracts£17.6m
2. 2Public Services Delivery Scotland7 contracts£176m
3. 3NHS Wales Shared Services Partnership5 contracts£36.4m
4. 4Western Health and Social Care Trust5 contracts£6.4m
5. 5Southern Health and Social Care Trust5 contracts£3.5m
6. 6The Clatterbridge Cancer Centre NHS Foundation Trust5 contracts£1.4m
7. 7Northern Health and Social Care Trust3 contracts£680k
8. 8UK Health Security Agency3 contracts—
9. 9University Hospitals Dorset NHS Foundation Trust2 contracts£4.2m
10. 10The Common Services Agency (more commonly known as Public Service Delivery Scotland) (PSDS)1 contract£2.7m

1. 1ALLOGA UK LIMITED10 contracts£5.3m
2. 2Bristol-Myers Squibb Pharmaceuticals6 contracts£5.3m
3. 3Fresenius Kabi6 contracts£9k
4. 4Roche5 contracts£69.9m
5. 5Novartis Pharmaceuticals UK Limited5 contracts£6.2m
6. 6SCIENSUS PHARMA SERVICES LIMITED5 contracts£5.8m
7. 7HealthNet Homecare5 contracts£1.8m
8. 8Pfizer Ltd4 contracts£1.3m
9. 9Bayer4 contracts£719k
10. 10Mercury Pharmaceuticals4 contracts£139k

Latest

• Provision of Pharmaceutical Services (official notice, opens in a new tab)

  £1.4m

  South West Yorkshire Partnership NHS Foundation Trust to Rowlands Pharmacy · Awarded 1 October 2026

• 2526-026-STA-WBS Provision of Altuvoct (Efanesoctocog alfa) recombinant FVII (official notice, opens in a new tab)

  £270k

  Velindre University NHS Trust to Swedish Orphan Biovitrum (Sobi) · Awarded 30 September 2026

• SECUKINUMAB 300 mg Pre-filled Injection 1 Pen Pack (official notice, opens in a new tab)

  £280k

  Belfast Health and Social Care Trust to Novartis Pharmaceuticals UK Limited · Awarded 7 September 2026

• GIVINOSTAT 8.86MG/ML ORAL SUSPENSION SUGAR-FREE, 140 mL, pack, PACK OF 1 (official notice, opens in a new tab)

  £475k

  Belfast Health and Social Care Trust to Polar Speed Distribution Limited · Awarded 7 September 2026

• ENCORAFENIB (BRAFTOVI) 75 mg Capsules (official notice, opens in a new tab)

  £180k

  Northern Health and Social Care Trust to PIERRE FABRE LIMITED · Awarded 17 August 2026

• Provision of Breyanzi CAR POS T-Cells (official notice, opens in a new tab)

  £140k

  The Clatterbridge Cancer Centre NHS Foundation Trust to Bristol-Myers Squibb Pharmaceuticals · Awarded 17 August 2026

• ANAKINRA (KINERET) 100 mg in 0.67mL Pre-filled Syringe (official notice, opens in a new tab)

  £300k

  Northern Health and Social Care Trust to ALLOGA UK LIMITED · Awarded 13 August 2026

• NP49426a Transition Medicines (official notice, opens in a new tab)

  £4.9m

  Public Services Delivery Scotland to Bowmed Ibisqus Limited, Brancaster Pharma Ltd, CELIX PHARMA LTD, CST Pharma and Colonis Pharma · Awarded 29 July 2026

• Contraceptive Medicines (official notice, opens in a new tab)

  £348k

  Public Health Scotland to Bayer, Gedeon Richter, Lupin Healthcare, Morningside Pharmaceuticals and Organon · Awarded 6 July 2026

• VUTRISIRAN 25MG/0.5ML SOLUTION FOR INJECTION PRE-FILLED SYRINGE, 0.5 mL (official notice, opens in a new tab)

  £350k

  Belfast Health and Social Care Trust to ALNYLAM UK LIMITED · Awarded 25 June 2026

Largest

• NP90425 Faricimab (Vabysmo®) (official notice, opens in a new tab)

  £48.4m

  Public Services Delivery Scotland to Roche · Awarded 25 February 2026

• NP90726m Vedolizumab (Entyvio®) (official notice, opens in a new tab)

  £47.9m

  Public Services Delivery Scotland to supplier not published · Awarded 24 June 2026

• Trastuzumab and Rituximab Subcut (official notice, opens in a new tab)

  £21.0m

  Public Services Delivery Scotland to Roche · Awarded 4 November 2025

• Transitional Drugs 7 (official notice, opens in a new tab)

  £16.8m

  NHS Wales Shared Services Partnership to Amgen Ltd, CELIX PHARMA LTD, Celltrion Healthcare, Fresenius Kabi and Gedeon Richter · Awarded 4 June 2026

• Ustekinumab (official notice, opens in a new tab)

  £6.5m

  NHS Wales Shared Services Partnership to Amgen Ltd, Celltrion Healthcare, Fresenius Kabi, Gedeon Richter and Sandoz Ltd · Awarded 4 June 2026

Supply of licensed generic, branded and biosimilar medicines to hospitals, prisons and other settings under national, regional or therapeutic-category contracts, including IV fluids, and of antidotes, antivirals and other medicines for government emergency stockpiles with storage and over-labelling.

• Medicines that have recently lost exclusivity
• Transition medicines
• Oncology generic medicines
• Generic anti-infectives
• Psychiatry and neurology medicines
• Heparins and anticoagulants
• Sodium chloride 0.9% and other IV fluids
• Inhalation anaesthetics
• NHS national branded and proprietary medicines tenders
• Hereditary angioedema therapies
• Multiple sclerosis medicines
• Anti-VEGF injections
• Botulinum toxin
• Branded oncology and antiviral medicines
• Insulin
• Branded inhalers
• Nerve agent antidotes such as pralidoxime and atropine
• Stockpile antibiotics
• Pandemic antivirals
• Stockpile supply with storage, over-labelling and distribution

• Vaccines (hlt.pharm.vaccines-immunisation)
• Plasma-derived medicines (hlt.pharm.blood-plasma-products)
• Aseptically prepared, unlicensed and investigational medicines (hlt.pharm.aseptic-specials-unlicensed)
• Wholesale distribution services (hlt.pharm.pharmaceutical-wholesale-distribution)
• Homecare delivery services (hlt.pharm.homecare-medicines)
• Radiopharmaceuticals and contrast media (hlt.pharm.radiopharmaceuticals-contrast-media)
• Nicotine replacement products (hlt.pharm.stop-smoking-products)
• Naloxone (hlt.pharm.naloxone-harm-reduction)

• Haematology analysers
• Managed equipment services